Valuation Morepen Laboratories Limited

Stocks

Market Closed - Bombay S.E. 18:23:43 02/11/2026 HKT			5-day change	1st Jan Change
108.05 ^INR	-4.97%		-12.33%	+163.09%

10-27	Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
09-28	Morepen Laboratories Limited Submits First U.S. ANDA For Sitagliptin Tablets USP	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	14,462	17,488	13,127	21,500	26,220	18,521
Change	-	20.93%	-24.94%	63.79%	21.95%	-29.36%
Enterprise Value (EV) ¹	15,415	18,663	13,162	21,620	26,219	20,059
Change	-	21.07%	-29.48%	64.27%	21.27%	-23.49%
P/E	15x	18.7x	33.4x	22.4x	21.8x	19.5x
PBR	3.4x	3.02x	1.74x	2.54x	2.27x	1.49x
PEG	-	-2.12x	-0.6x	0x	1.3x	-0.9x
Capitalization / Revenue	1.21x	1.12x	0.92x	1.26x	1.45x	1.03x
EV / Revenue	1.29x	1.2x	0.93x	1.27x	1.45x	1.11x
EV / EBITDA	12.5x	13.9x	19.2x	14x	16.2x	18.2x
EV / EBIT	15.7x	15.8x	23.5x	15.8x	18.1x	22.5x
EV / FCF	-54.9x	-13x	-47.9x	-94x	-11.8x	-13.5x
FCF Yield	-1.82%	-7.71%	-2.09%	-1.06%	-8.51%	-7.39%
Dividend per Share ²	-	-	-	-	0.2	0.2
Rate of return	-	-	-	-	0.42%	0.59%
EPS ²	2.15	1.96	0.77	1.88	2.2	1.731
Distribution rate	-	-	-	-	9.09%	11.6%
Net sales ¹	11,980	15,558	14,220	17,019	18,116	18,057
EBITDA ¹	1,230	1,338	686.6	1,545	1,620	1,101
EBIT ¹	981.7	1,180	560.8	1,366	1,451	891.9
Net income ¹	970.9	1,017	386.8	961.6	1,180	948.8
Net Debt ¹	953.1	1,174	34.98	120.5	-0.928	1,538
Reference price ²	32.15	36.60	25.68	42.06	47.85	33.80
Nbr of stocks (in thousands)	449,826	477,826	511,169	511,169	547,954	547,954
Announcement Date	4/9/21	2/9/22	4/9/23	1/8/24	12/8/25	1/9/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MOREPEN LABORATORIES LIMITED	-	-	-	-	656M
ELI LILLY AND COMPANY	41.42x	14.01x	31.06x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.35%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	97.38x	6.07x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.87x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-40.86x	7.45x	46.76x	1.94%	212B
Average	30.40x	7.39x	21.67x	2.01%	426.26B
Weighted average by Cap.	36.41x	8.82x	22.82x	1.69%